Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kevin Morley
Observed names:
Kevin T. Morley,
Morley, Kevin
Observed institutions:
Loyola University Medical Center,
Karolinska University Hospital,
University of California, San Francisco,
Loyola University Chicago,
University of Alabama at Birmingham,
Loyola Medicine
show all 6
ORCID:
0000-0002-7034-0938
Observed ORCID:
0000-0002-7034-0938
OpenAlex ID:
A5084562782
Predicting breast cancer response to neoadjuvant treatment using multi-feature MRI: results from the I-SPY 2 TRIAL
2020
·
Wen Li
, David C. Newitt
, et al.
·
npj Breast Cancer
·
90
PDF
Breast MRI during Neoadjuvant Chemotherapy: Lack of Background Parenchymal Enhancement Suppression and Inferior Treatment Response
2021
·
Natsuko Onishi
, Wen Li
, et al.
·
Radiology
·
37
PDF
An accessory sex gland aggression-promoting chemosignal in male mice.
1986
·
David W. Ingersoll
, Kevin T. Morley
, et al.
·
Behavioral Neuroscience
·
27
Effect of Longitudinal Variation in Tumor Volume Estimation for MRI-guided Personalization of Breast Cancer Neoadjuvant Treatment
2023
·
Natsuko Onishi
, Teffany Joy Bareng
, et al.
·
Radiology Imaging Cancer
·
10
Metadata record for the manuscript: Predicting breast cancer response to neoadjuvant treatment using multi-feature MRI: results from the I-SPY 2 TRIAL
2020
·
Li, Wen
, Newitt, David C.
, et al.
·
Figshare
·
2
Abstract PD9-04: Breast cancer subtype specific association of pCR with MRI assessed tumor volume progression during NAC in the I-SPY 2 trial
2020
·
Wen Li
, Natsuko Onishi
, et al.
·
Cancer Research
Abstract P6-02-01: The effect of background parenchymal enhancement on the predictive performance of functional tumor volume measured in MRI
2020
·
Wen Li
, Natsuko Onishi
, et al.
·
Cancer Research
Show more works
View as search
Works count:
8
Citation count:
188
H-index:
5
I10-index:
5
Year
Topic
Type
